Sanofi and Boehringer in OTC asset swap talks

15 December 2015 - Deborah Wilkes

Sanofi and Boehringer Ingelheim have entered into exclusive negotiations on a business swap that would see Sanofi become a global leader in consumer healthcare and Boehringer Ingelheim become the second-largest animal health company. The two companies aim to close the potential transaction in the fourth quarter of 2016.